Intervention not reported
Nitrates(1 RCT, 118 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes nitrates(1 RCT, 118 participants) (very low certainty).
1 finding from 1 review
HR 1.27 [0.61, 2.66]
Studies not reported
Very low
Intervention not reported
Beta‐blockers + sclerotherapy(1 RCT, 141 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes beta‐blockers + sclerotherapy(1 RCT, 141 participants) (very low certainty).
1 finding from 1 review
HR 0.92 [0.41, 2.08]
Studies not reported
Very low
Intervention not reported
No active intervention(2 RCTs, 208 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes no active intervention(2 RCTs, 208 participants) (very low certainty).
1 finding from 1 review
HR 2.71 [0.97, 7.68]
Studies not reported
Very low
Intervention not reported
No active intervention(10 RCTs, 1200 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to higher no active intervention(10 RCTs, 1200 participants) (low certainty).
1 finding from 1 review
HR 2.04 [1.5, 2.78]
Studies not reported
Low
Intervention not reported
Sclerotherapy(3 RCTs, 175 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes sclerotherapy(3 RCTs, 175 participants) (very low certainty).
1 finding from 1 review
HR 1.02 [0.33, 3.27]
Studies not reported
Very low
Intervention not reported
Nitrates(1 RCT, 52 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to higher nitrates(1 RCT, 52 participants) (low certainty).
1 finding from 1 review
HR 6.4 [1.58, 47.42]
Studies not reported
Low
Intervention not reported
Sclerotherapy(5 RCTs, 320 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes sclerotherapy(5 RCTs, 320 participants) (very low certainty).
1 finding from 1 review
HR 1.35 [0.95, 1.92]
Studies not reported
Very low
Intervention not reported
Beta‐blockers + nitrates(2 RCTs, 203 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes beta‐blockers + nitrates(2 RCTs, 203 participants) (very low certainty).
1 finding from 1 review
HR 0.84 [0.44, 1.64]
Studies not reported
Very low
Intervention not reported
Nitrates(3 RCTs, 298 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes nitrates(3 RCTs, 298 participants) (very low certainty).
1 finding from 1 review
HR 1.19 [0.66, 2.11]
Studies not reported
Very low
Intervention not reported
Beta‐blockers + sclerotherapy(2 RCTs, 167 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to higher beta‐blockers + sclerotherapy(2 RCTs, 167 participants) (low certainty).
1 finding from 1 review
HR 2.08 [1.03, 4.08]
Studies not reported
Low
Intervention not reported
Interventions · people with liver cirrhosis and previous oesophageal variceal bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Sclerotherapy plus Nitrates(1 RCT; 76 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to lower sclerotherapy plus Nitrates(1 RCT; 76 participants) (moderate certainty).
1 finding from 1 review
HR 0.19 [0.02, 0.86]
Studies not reported
Moderate
Intervention not reported
Beta‐blockers(1 RCT; 91 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers(1 RCT; 91 participants) (very low certainty).
1 finding from 1 review
OR 0.47 [0.13, 1.53]
Studies not reported
Very low
Intervention not reported
Beta‐blockers plus Sclerotherapy(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers plus Sclerotherapy(No direct RCT) (very low certainty).
1 finding from 1 review
OR 1.29 [0.28, 5.7]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to higher beta‐blockers(No direct RCT) (low certainty).
1 finding from 1 review
OR 11.86 [1.16, 427.95]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Sclerotherapy(2 RCTs; 71 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(2 RCTs; 71 participants) (low certainty).
1 finding from 1 review
OR 1.46 [0.36, 6.06]
Studies not reported
Low
Intervention not reported
Sclerotherapy · people with liver cirrhosis and previous oesophageal variceal bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
No active intervention(1 RCT; 40 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to lower no active intervention(1 RCT; 40 participants) (low certainty).
1 finding from 1 review
OR 0.22 [0.05, 0.86]
Studies not reported
Low
Intervention not reported
TIPS(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to lower TIPS(No direct RCT) (low certainty).
1 finding from 1 review
OR 0.02 [0, 0.17]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) (low certainty).
1 finding from 1 review